499
Views
0
CrossRef citations to date
0
Altmetric
Clinical Psychology

Effectiveness of the integration of traditional Chinese medicine and western medicine (integrative medicine) for treating liver stagnation and spleen deficiency in major depressive disorder: a randomized controlled trial protocol

ORCID Icon, ORCID Icon, & ORCID Icon
Article: 2301182 | Received 28 Jul 2023, Accepted 28 Dec 2023, Published online: 31 Jan 2024

References

  • Amuda, Y. J., Chikhaoui, E., Hassan, S., & Dhali, M. (2021). Qualitative exploration of legal, economic and health impacts of Covid-19 in Saudi Arabia. Emerging Science Journal, 6, 1–10. https://doi.org/10.28991/esj-2022-SPER-01
  • Askelund, A. D., Schweizer, S., Goodyer, I. M., & van Harmelen, A.-L. (2019). Positive memory specificity is associated with reduced vulnerability to depression. Nature Human Behaviour, 3(3), 265–273. https://doi.org/10.1038/s41562-018-0504-3
  • Bech, P., Allerup, P., Gram, L. F., Reisby, N., Rosenberg, R., Jacobsen, O., & Nagy, A. (2010). The hamilton depression scale. evaluation of objectivity using logistic models. Acta Psychiatrica Scandinavica, 63(3), 290–299. https://doi.org/10.1111/j.1600-0447.1981.tb00676.x
  • Bech, P., Gram, L. F., Dein, E., Jacobsen, O., Vitger, J., & Bolwig, T. G. (1975). Quantitative rating of depressive states: correlation between clinical assessment, Beck’s self‐rating scale and Hamilton’s objective rating scale. Acta Psychiatrica Scandinavica, 51(3), 161–170. https://doi.org/10.1111/j.1600-0447.1975.tb00002.x
  • Belica-Pacha, S., Daśko, M., Buko, V., Zavodnik, I., Miłowska, K., & Bryszewska, M. (2021). Thermodynamic Studies of Interactions between Sertraline Hydrochloride and Randomly Methylated β-Cyclodextrin Molecules Supported by Circular Dichroism Spectroscopy and Molecular Docking Results. International Journal of Molecular Sciences, 22(22), 12357. https://doi.org/10.3390/IJMS222212357
  • Blum, S. I., Tourkodimitris, S., & Ruth, A. (2015). Evaluation of functional health and well-being in patients receiving levomilnacipran ER for the treatment of major depressive disorder. Journal of Affective Disorders, 170, 230–236. https://doi.org/10.1016/j.jad.2014.09.005
  • Borgsted, C., Hoegsted, E., Henningsson, S., Pinborg, A., Ganz, M., & Frokjaer, V. G. (2022). Hippocampal volume changes in a pharmacological sex-hormone manipulation risk model for depression in women. Hormones and Behavior, 145, 105234. Available from: https://doi.org/10.1016/J.YHBEH.2022.105234
  • Butler, T., Schofield, P. W., Knight, L., Ton, B., Greenberg, D., Scott, R. J., Grant, L., Keech, A. C., Gebski, V., Jones, J., Ellis, A., Weatherburn, D., Wilhelm, K., Jones, A., Churchill, A., Allnutt, S., Mitchell, P. B., Chappell, D., D’Este, C., Villa, D., & Carr, V. (2021). Sertraline hydrochloride for reducing impulsive behaviour in male, repeat-violent offenders (ReINVEST): protocol for a phase IV, double-blind, placebo-controlled, randomised clinical trial. BMJ Open, 11(9), e044656. https://doi.org/10.1136/BMJOPEN-2020-044656
  • Castro Gonçalves, A. B., Ferreira Fratelli, C., Saraiva Siqueira, J. W., Canongia de Abreu Cardoso Duarte, L., Ribeiro Barros, A., Possatti, I., Lima Dos Santos, M., de Souza Silva, C. M., & Rodrigues da Silva, I. C. (2022). MAOA uVNTR Genetic Variant and Major Depressive Disorder: A Systematic Review. Cells, 11(20), 3267. https://doi.org/10.3390/CELLS11203267
  • Chand, S. P. (2022). Depression. In: StatPearls. StatPearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK430847/.
  • Chang, N., Zhao, L., & Hu, J. (2020). Effect of sertraline on negative emotions and adverse cardiovascular events in patients with coronary heart disease and depression. Chin Community Phys, 36(3), 2.
  • Chen, H., Du, Y., & Jia, G. Z. (2003). Application of factor analysis in structural validity test of family burden scale. China Health Stat, 20(2), 2.
  • Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J. P. A., & Geddes, J. R. (2018). Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet (London, England), 391(10128), 1357–1366. https://doi.org/10.1016/s0140-6736(17)32802-7
  • Fanaja, R. A., Pradana, M., Eka Saputri, M., & Utami, D. G. (2023). Knowledge management as driver of women’s entrepreneurial innovativeness. Journal of Human, Earth, and Future, 4(1), 1–9. https://doi.org/10.28991/HEF-2023-04-01-01
  • Guo, W., Cao, X., Sheng, L., Li, J., Zhang, L., & Ma, Y. (2020). Expert Consensus on the Diagnosis and Treatment of Depression with Integrated Traditional Chinese and Western Medicine, https://doi.org/10.3969/j.issn.1672-6731.2021.12.002
  • Guyatt, G. H., Feeny, D. H., & Patrick, D. L. (1993). Measuring health-related qol. Annals of Internal Medicine, 118(8), 622–629. https://doi.org/10.7326/0003-4819-118-8-199304150-00009
  • Hongsheng, C., Xiaohua, D., Jichun, L., & Qingguo, W. (2011). Analysis of the origin of Chinese medicine. Journal of Beijing University of Traditional Chinese Medicine, 34(10), 653–658.
  • Hou, Z., Jiang, W., Yin, Y., Zhang, Z., & Yuan, Y. (2016). The current situation on major depressive disorder in China: Research on mechanisms and clinical practice. Neuroscience Bulletin, 32(4), 389–397. https://doi.org/10.1007/s12264-016-0037-6
  • Jeong, J.-H., Bahk, W.-M., Woo, Y. S., Yoon, B.-H., Lee, J. G., Kim, W., Sohn, I., Park, S.-Y., Shim, S.-H., Seo, J. S., Choo, I. H., Yang, C.-M., Jung, M. H., Jon, D.-I., & Kim, M.-D. (2023). Korean medication algorithm project for bipolar disorder 2022: Comparisons with other treatment guidelines. Clinical Psychopharmacology and Neuroscience: The Official Scientific Journal of the Korean College of Neuropsychopharmacology, 21(1), 32–48. https://doi.org/10.9758/CPN.2023.21.1.32
  • Jiang, L. (2019). The structure and criterion validity of the Chinese version of Beck Depression Scale. (2nd edition) among Chinese college students. Medical Dissertation, Hunan Normal University.
  • Kessler, R. C., & Bromet, E. J. (2013). The epidemiology of depression across cultures. Annual Review of Public Health, 34(1), 119–138. https://doi.org/10.1146/annurev-publhealth-031912-114409
  • Kong, X., Fang, H., Li, X., Zhang, Y., & Guo, Y. (2022). Effects of auricular acupressure on dysmenorrhea: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Endocrinology, 13, 1016222. https://doi.org/10.3389/FENDO.2022.1016222
  • König, H., König, H.-H., & Konnopka, A. (2019). The excess costs of depression: a systematic review and meta-analysis. Epidemiology and Psychiatric Sciences, 29, e30. https://doi.org/10.1017/S2045796019000180
  • Kronenberg, S., Apter, A., Brent, D., Schirman, S., Melhem, N., Pick, N., Gothelf, D., Carmel, M., Frisch, A., & Weizman, A. (2007). Serotonin transporter polymorphism (5-httlpr) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders. Journal of Child and Adolescent Psychopharmacology, 17(6), 741–750. https://doi.org/10.1089/cap.2006.0144
  • Künzel, H. E., Zobel, A. W., Nickel, T., Ackl, N., Uhr, M., Sonntag, A., Ising, M., & Holsboer, F. (2003). Treatment of depression with the crh-1-receptor antagonist r121919: endocrine changes and side effects. Journal of Psychiatric Research, 37(6), 525–533. https://doi.org/10.1016/S0022-3956(03)00070-0
  • Licht, R. W., Qvitzau, S., Allerup, P., & Bech, P. (2005). Validation of the Bech–Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression; is the total score a valid measure of illness severity? Acta Psychiatrica Scandinavica, 111(2), 144–149. https://doi.org/10.1111/j.1600-0447.2004.00440.x
  • Liu, J. (2019). To observe the effect of biochemical relaxation combined with integrated traditional Chinese and Western medicine nursing in the intervention of postpartum depression. Chin J Mod Drug Appl, 13(11), 3.
  • Liu, J., Hu, S., & Zhan, Y. (2021). The efficacy of Xiaoyao Powder combined with paroxetine in the treatment of senile depression after fracture and its effect on serum NE and 5-HT. Contemp Med, 27(28), 3.
  • Li, S., Wang, W., Song, Y., & Wei, J. (2021). Clinical effect of Xiaoyao loose combined sputum tongluo decoction plus duloxetine hydrochloride tablets in the treatment of depression. China Med Herald, 18(04), 111–114.
  • Li, W., Xu, M., & Gao, Y. (2006). A study on the reliability and validity of Hamilton Depression Scale (HAMD-6). Chin J Nerv Ment Dis, 32(2), 4.
  • Li, X., & Zhang, C. (2020). Comparative efficacy of nine antidepressants in treating Chinese patients with post-stroke depression: A network meta-analysis. Journal of Affective Disorders, 266, 540–548. https://doi.org/10.1016/j.jad.2020.02.005
  • Li, Y., Zhao, Z., Liu, S., Yu, Y., Guo, J., & Guo, R. (2021). An overview of traditional Chinese medicine research on depression, liver depression and spleen deficiency. Chin J Tradit Chin Med, 36(1), 4.
  • Lu, T., Li, Y., Xia, P., Zhang, G., & Wu, D. (2014). Reliability and validity analysis of Pittsburgh Sleep Quality Index. Chongqing Med, 003), 260–263. (
  • Madsen, I., Lange, T., Borritz, M., & Rugulies, R. (2015). Burnout as a risk factor for antidepressant treatment - a repeated measures time-to-event analysis of 2936 danish human service workers. Journal of Psychiatric Research, 65, 47–52. https://doi.org/10.1016/j.jpsychires.2015.04.004
  • Malberg, J. E. (2004). Implications of adult hippocampal neurogenesis in antidepressant action. Journal of Psychiatry & Neuroscience: JPN, 29(3), 196–205.
  • McCullough, D., Harrison, T., Boddy, L. M., Enright, K. J., Amirabdollahian, F., Schmidt, M. A., Doenges, K., Quinn, K., Reisdorph, N., Mazidi, M., Lane, K. E., Stewart, C. E., & Davies, I. G. (2022). The Effect of Dietary Carbohydrate and Fat Manipulation on the Metabolome and Markers of Glucose and Insulin Metabolism: A Randomised Parallel Trial. Nutrients, 14(18), 3691. https://doi.org/10.3390/NU14183691
  • Miret, M., Ayuso-Mateos, J. L., Sanchez-Moreno, J., & Vieta, E. (2013). Depressive disorders and suicide: epidemiology, risk factors, and burden. Neuroscience and Biobehavioral Reviews, 37(10 Pt 1), 2372–2374. https://doi.org/10.1016/j.neubiorev.2013.01.008
  • Montgomery, S. A., Nielsen, R. Z., Poulsen, L. H., & Häggström, L. (2014). A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Human Psychopharmacology, 29(5), 470–482. https://doi.org/10.1002/hup.2424
  • Rajpurkar, P., Yang, J., Dass, N., Vale, V., Keller, A. S., Irvin, J., Taylor, Z., Basu, S., Ng, A., & Williams, L. M. (2020). Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial. JAMA Network Open, 3(6), e206653. https://doi.org/10.1001/jamanetworkopen.2020.6653
  • Ren, X., Yu, S., Dong, W., Yin, P., Xu, X., & Zhou, M. (2020). The burden of depression in China, 1990–2017: Findings from the global burden of disease study 2017. Journal of Affective Disorders, 268, 95–101. https://doi.org/10.1016/j.jad.2020.03.011
  • Rongjuan, G., Miao, Y., Jialin, W., Aiqing, H., Ming, L., & Yunling, Z. (2015). A study of the Chinese medicine evidence elements identification scale for depression. Journal of Beijing University of Chinese Medicine, 38(8), 561–565.
  • Sankova, M. V., Kytko, O. V., Vasil’ev, Y. L., Aleshkina, O. Y., Diachkova, E. Y., Darawsheh, H. M., Kolsanov, A. V., & Dydykin, S. S. (2021). Medical students’ reactive anxiety as a quality criterion for distance learning during the Sars-Cov-2 pandemic. Emerging Science Journal, 5, 86–93. https://doi.org/10.28991/esj-2021-SPER-07
  • Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., Bang-Jensen, B. L., Bertolacci, G. J., Bloom, S. S., Castellano, R., Castro, E., Chakrabarti, S., Chattopadhyay, J., Cogen, R. M., Collins, J. K., … Ferrari, A. J. (2021). Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. The Lancet, 398(10312), 1700–1712. https://doi.org/10.1016/s0140-6736(21)02143-7
  • Vujovic, V., Arsova, S., Gerazova-Pejoska, V., Hadzi-Angelkovski, G., Ristova Dimova, T., Dojcinovski, I., et al. (2005). Anxiety and depression treatment with asentra (sertraline). In Diagnostic Entities F 41.2, F 32.0, F 32.1, F 32.2. Regional & Intersectional Congress, (3), 12–15.
  • Wang, D., Li, T., Ron, J., Mao, M., Yang, Y., Feng, Y., & Yan, Y. (2022). Efficacy and Safety of Xiaoyao Recipe in the Treatment of Poststroke Depression: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine, 2022, 1–10. https://doi.org/10.1155/2022/4385783
  • Wang, D., Li, T., Ron, J., Mao, M., Yang, Y., Feng, Y., & Yan, Y. (2022). Efficacy and Safety of Xiaoyao Recipe in the Treatment of Poststroke Depression: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine: eCAM, 2022, 4385783. https://doi.org/10.1155/2022/4385783
  • Wang, S., Shan, D., Liu, H., Liu, X., Yu, H., Ma, D., & Wang, L. (2022). Effects of moxibustion on the expression of CREB and P-CREB in hippocampal in rats with hepatic depression and spleen deficiency depression. J Liaoning Univ Chin Med, 11), 170–173. (https://doi.org/10.13194/j.issn.1673-842x.2022.11.035
  • Wang, Z., Yuan, C., Huang, J., Li, Z., Chen, J., & Zhang, H. (2011). Reliability and validity of Chinese version of Beck Depression Scale 2nd Edition in patients with depression. Chin Ment Health J, 25(6), 5.
  • Yang, F., Chen, J., Zou, X., & Ling, G. (2020). The correlation between depression and osteoporosis in the elderly from renal and yang deficiency was discussed. Chin J Tradit Chin Med, 35(9), 4.
  • Yuan, J., Pei, Q., Qu, M., & Zheng, Q. (2022). Clinical effect of Xiaoyao Flavor Prescription in the treatment of hepatic depression and spleen deficiency depression. China Med Herald, 19(28), 7–10.
  • Zeng, Z., & Liu, J. (2016). The State Council of the CPC Central Committee issued the "Healthy China 2030" Planning Outline. Gazette of the State Council of the People’s Republic of China, 32, 5–20.
  • Zhang, F. (2012). Modified Xiaoyaosan for 60 cases of depression. J Pract Tradit Chin Intern Med, 26(6), 2.
  • Zhang, L., Zhuang, Z., & Wang, J. (2015). Clinical study of Xiaoyaosan combined with fluoxetine hydrochloride capsule in the treatment of postoperative depression of breast cancer. J Tradit Chin Med, 6, 3.
  • Zhao, Z. (2017). [Therapeutic effect and mechanism of rosiglitazone on depression in mice caused by chronic mild unpredictable stress ]. [Doctoral thesis]. Nanjing Medical University.
  • Zhou, J., Wang, R., Hu, Z., Wang, Y., Dong, Y., & Wang, Y. (2021). Efficacy of acupuncture and medication in the treatment of mild to moderate depression. Shanghai J Acupunct Moxibustion, 40(011), 1312–1317.